We are fortunate to have this CEO. He is a strategic thinker and really does know the business and its markets. His messaging about how he is aiming to build a sustainable business shows significant acumen.
It was good to hear about the three options being discussed with BARDA and the FDA re the pivotal trial. And it is now clear how the trial data and analysis will influence not just the US market but also entry into Japan.
We are fortunate to have this CEO. He is a strategic thinker and...
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.29 |
Change
0.170(8.02%) |
Mkt cap ! $1.580B | |||
| Open | High | Low | Value | Volume |
| $2.20 | $2.32 | $2.19 | $8.235M | 3.626M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7027 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 17480 | 5 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.30 |
Change
0.170 ( 9.07 %) |
||||
| Open | High | Low | Volume | ||
| $2.19 | $2.32 | $2.19 | 594302 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| PNV (ASX) Chart |